BTCY - Biotricity

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Biotricity reports preliminary Q3 results
• Biotricity reports Q2 results
• Biotricity posts $14M revenue run rate in August
• Biotricity GAAP EPS of -$0.06, revenue of $3.02M
• Biotricity sees record Q1-FY2024 recurring revenue growth
• Biotricity FQ1'24 revenue estimated to rise by ~40%
• Biotricity announces reverse stock split
• Biotricity's April annualized revenue run rate reaches $13M
• Biotricity touches $12M in annualized revenue
• Biotricity GAAP EPS of -$0.09 in-line, revenue of $2.46M beats by $0.06M
• Biotricity stock rises on surpassing $10M in annual revenue run rate
• Biotricity GAAP EPS of -$0.09 misses by $0.01, revenue of $2.4M misses by $0.14M
• Biotricity GAAP EPS of -$0.09, revenue of $2.06M
• Biotricity Non-GAAP EPS of -$0.11 in-line, revenue of $2.15M beats by $0.04M
• Biotricity to enter Russell Microcap Index
• Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022
• Biotricity Non-GAAP EPS of -$0.12, revenue of $1.93M
• Biotricity receives FDA 510(k) clearance for Biotres Cardiac Monitoring Device
• Biotricity offers its new heart monitoring system on Amazon
• Biotricity on the rise after announcing $12M debt financing